Cellectis

Cellectis Dividend

Dividend of Cellectis (CLLS) as of Oct 20, 2026.

Dividend

0.00USD

Last updated:

How much dividend does Cellectis 2026 pay?

According to the latest status from October 2026, Cellectis paid a total of 0.00 USD per share in dividends within the last 12 months. With the current Cellectis price of 0.93 USD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical Cellectis Dividends

Historical Cellectis Dividends
PaydateDividend

The Cellectis Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2023
0.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD
Jan 1, 2026 (e)
0.00 USD
Jan 1, 2027 (e)
0.00 USD
Jan 1, 2028 (e)
0.00 USD
Jan 1, 2029 (e)
0.00 USD
Jan 1, 2030 (e)
0.00 USD
The Cellectis Dividend history
YEARDividendYoY
est0.00USD—
est0.00USD—
est0.00USD—
est0.00USD—
est0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—

Is the Cellectis Dividend Safe?

Cellectis has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding Cellectis's Dividend Distributions

Cellectis’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Cellectis's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Cellectis's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Cellectis’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Cellectis Stock analysis

What does Cellectis do? Cellectis SA, headquartered in Paris, France, is a clinical-stage biotechnology company specializing in gene-editing technologies. It develops allogeneic CAR-T cell therapies for immuno-oncology, including product candidates like BALLI-01 for relapsed/refractory acute lymphoblastic leukemia and NatHaLi-01 for B-cell non-Hodgkin's lymphoma. The company also focuses on gene therapy for other therapeutic areas, with additional candidates targeting large B-cell lymphoma and renal cell carcinoma. Founded in 1999, it has 222 employees and has been listed on the stock market since 2007. Cellectis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cellectis stock

Cellectis paid dividends every year for the past 0 years.

Cellectis is assigned to the 'Health' sector.

The dividends of Cellectis are distributed in USD.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

All Key Metrics — Cellectis